SEC Form 4 · accession 0001654954-17-011773
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald R Blanck
Director
Period of report
Dec 18, 2017
Accepted (ET)
Dec 20, 2017 · 9:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 18, 2017 | P | 6,475 | $0.4642 | A | 13,624 | D | |
| Common Stock | Dec 18, 2017 | P | 6,475 | $0.445 | A | 20,099 | D |
Table II — derivative securities
No Table II lines on this filing.